Patou Gary Insider Trades

Insider Trading History

Track insider trading activity for Patou Gary. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $909k 17,012 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$523k 17,012 shares
$30.73
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.41M 26,424 shares
Last Trade
Nov 22, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$67.5k 1,695 shares
$39.80
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.26M 23,573 shares
Last Trade
Nov 22, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$201k 4,891 shares
$41.08
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.45M 27,073 shares
Last Trade
Nov 22, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$271k 6,586 shares
$41.15
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $0 0 shares
Last Trade
Nov 22, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$271k 6,586 shares
$41.15
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $831k 15,542 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$593k 15,542 shares
$38.16
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $262k 4,902 shares
Last Trade
Dec 14, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$312k 7,598 shares
$41.05
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.53M 28,673 shares
Last Trade
Dec 13, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$120k 3,022 shares
$39.68
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.6M 29,951 shares
Last Trade
Dec 13, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$575k 14,402 shares
$39.90
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.26M 23,573 shares
Last Trade
Dec 13, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$759k 18,978 shares
$39.99
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $0 0 shares
Last Trade
Dec 13, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$317k 7,944 shares
$39.90
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $988k 18,475 shares
Last Trade
Jun 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$720k 18,475 shares
$38.96
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.26M 23,573 shares
Last Trade
Nov 25, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$67.4k 1,937 shares
$34.79
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.37M 25,630 shares
Last Trade
Nov 25, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$71.6k 2,057 shares
$34.81
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $0 0 shares
Last Trade
Nov 25, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$71.6k 2,057 shares
$34.81
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.36M 25,510 shares
Last Trade
Nov 25, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.12k 120 shares
$34.37
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $962k 18,000 shares
Last Trade
Jun 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$542k 18,000 shares
$30.11
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $962k 18,000 shares
Last Trade
Jun 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$542k 18,000 shares
$30.11
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.37M 25,630 shares
Last Trade
Dec 08, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$56.5k 2,057 shares
$27.45
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $0 0 shares
Last Trade
Dec 08, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$56.5k 2,057 shares
$27.45
$53.46

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up